Pathstone Family Office’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,225
Closed -$481K 1567
2022
Q3
$481K Buy
13,225
+6,098
+86% +$264K ﹤0.01% 1089
2022
Q2
$341K Buy
7,127
+432
+6% +$20K 0.01% 732
2022
Q1
$385K Buy
+6,695
New +$352K 0.01% 648
2021
Q4
Sell
-5,389
Closed -$359K 946
2021
Q3
$359K Buy
5,389
+711
+15% +$55.5K 0.01% 619
2021
Q2
$430K Buy
+4,678
New +$461K 0.01% 522
2021
Q1
Sell
-80
Closed -$12K 1176
2020
Q4
$12K Buy
+80
New +$11.3K ﹤0.01% 848

Other funds holding PRLB

Pathstone Family Office's PRLB Position: Q4 2022 in Review

Pathstone Family Office sold out of Protolabs (PRLB) in Q4 2022, closing a stake of 13,225 shares — an estimated $481K sold.

Pathstone Family Office first reported a position in PRLB in Q4 2020 and held it in 6 quarters. The position peaked at $481K in Q3 2022. 199 funds tracked by Wall St. Rank hold PRLB as of Q4 2022.

  • Pathstone Family Office reported no remaining Protolabs position as of Q4 2022 after selling out during the quarter.
  • Pathstone Family Office sold 13,225 Protolabs shares in Q4 2022, an estimated $481K.
  • Pathstone Family Office first reported a position in Protolabs in Q4 2020 and held it in 6 quarters.
  • Pathstone Family Office's Protolabs position peaked at $481K in Q3 2022.
  • 199 funds tracked by Wall St. Rank held Protolabs as of Q4 2022.

Based on Pathstone Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.